Objectives: It was aimed to investigate if there were anysignificant corresponding changes on adipokine levels inobese subjects who achieved a 10% reduction in bodyweight.Methods: Thirty obese and 25 healthy adultswere enrolled inpresent study, and serum levels of vaspin, apelin-13, obestatin,and insulin were determined with the ELISA method.Results: The serum obestatin and apelin-13 values of theobese group obtained as basal and after weight loss wassignificantly lower than in controls (p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objectives: It was aimed to investigate if there were anysignificant corresponding changes on adipokine levels inobese subjects who achieved a 10% reduction in bodyweight.Methods: Thirty obese and 25 healthy adultswere enrolled inpresent study, and serum levels of vaspin, apelin-13, obestatin,and insulin were determined with the ELISA method.Results: The serum obestatin and apelin-13 values of theobese group obtained as basal and after weight loss wassignificantly lower than in controls (p
📊
Key Findings & Data:Objectives: It was aimed to investigate if there were anysignificant corresponding changes on adipokine levels inobese subjects who achieved a 10% reduction in bodyweight.Methods: Thirty obese and 25 healthy adultswere enrolled inpresent study, and serum levels of vaspin, apelin-13, obestatin,and insulin were determined with the ELISA method.Results: The serum obestatin and apelin-13 values of theobese group obtained as basal and after weight loss wassignificantly lower than in controls (p
💡
Conclusion & Impact:Objectives: It was aimed to investigate if there were anysignificant corresponding changes on adipokine levels inobese subjects who achieved a 10% reduction in bodyweight.Methods: Thirty obese and 25 healthy adultswere enrolled inpresent study, and serum levels of vaspin, apelin-13, obestatin,and insulin were determined with the ELISA method.Results: The serum obestatin and apelin-13 values of theobese group obtained as basal and after weight loss wassignificantly lower than in controls (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Objectives: It was aimed to investigate if there were anysignificant corresponding changes on adipokine levels inobese subjects who achieved a 10% reduction in bodyweight.Methods: Thirty obese and 25 healthy adultswere enrolled inpresent study, and serum levels of vaspin, apelin-13, obestatin,and insulin were determined with the ELISA method.Results: The serum obestatin and apelin-13 values of theobese group obtained as basal and after weight loss wassignificantly lower than in controls (p
Özet
Amaç: Bu çalışmada obez bireylerin vücut ağırlıklarında% 10 azalma sağlandığında adipokin düzeylerinde anlamlı bir değişiklik olup olmadığının araştırılması amaçlanmıştır. Gereç ve Yöntemler: Otuz beş obez, 25 sağlıklı yetişkin çalışmaya alındı ve serum vaspin, apelin-13, obestatin ve insülin düzeyleri ELISA yöntemi ile belirlendi. Bulgular: Obez grubun bazal ve kilo kaybı sonrası elde edilen serumobestatin ve apelin-13 değerleri, kontrollere göre anlamlı derecede düşüktü (sırasıyla p
🔖
Cite This Article
NOYAN, T., FİGEN, C. C., ÖZDEMİR, Ö. (2022). The investigation effect of weight loss on serum vaspin, apelin-13, and obestatin levels in obese individual. Türk Biyokimya Dergisi, Cilt: 45 - Sayı: 6, 725–736. https://ajindex.com/articles/620821
Sikaris KA. The clinical biochemistry of obesity. Clin Biochem Rev 2004;25:165–81
Isacco L, Miles-Chan JL. Gender-specific considerations in physical activity, thermogenesis and fat oxidation: implications for obesity management.Obes Rev 2018;1:73-83
Upadhyay J, Farr O, Perakakis N, Ghaly W, Mantzoros C. Obesity as a disease. Med Clin 2018;102:13–33
Hu FB. Obesity and mortality: Watch your waist, not just your weight. Arc Intern Med 2007;167:875–6
Satman I. The obesity problem in Turkey. Turkiye Klinikleri J Gastroenterohepatol–Special Topics 2016;9:1–11
Pi-Sunyer X. The medical risks of obesity. Postgrad Med 2009; 121:21–33
Na YM, Park HA, Kang JH, Cho YG, Kim KW, Hur YI, et al. Obesity, obesity related disease, and disability. Korean J Fam Med 2011; 32:412–22
Coelho M, Oliveira T, Fernandes R. Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci 2013;9:191–200
Saely CH, Geiger K, Drexel H. Brown versus white adipose tissue: a mini-review. Gerontology 2012;58:15–23
Leal Vde O, Mafra D. Adipokines in obesity. Clin Chim Acta 2013; 419:87–94
Esmaili S, Hemmati M, Karamian M. Physiological role of adiponectin in different tissues: a review. Arch Physiol Biochem 2020;126:67–73
Beberashvili I, Azar A, Abu Hamad R, Sinuani I, Feldman L, Maliar A, et al. Abdominal obesity in normal weight versus overweight and obese hemodialysis patients: Associations with nutrition, inflammation, muscle strength, and quality of life. Nutrition 2019; 59:7–13
Montazerifar F, Bakhshipour AR, KarajibaniM, Torki Z, Dashipour AR. Serum omentin-1, vaspin and apelin levels and central obesity in patients with nonalcoholic fatty liver disease. J Res Med Sci 2017;30:70
Zulet MA, Puchau B, Navarro C, Martí A, Martínez JA. Inflammatory biomarkers: the link between obesity and associated pathologies. Nutr Hosp 2007;22:511–27
Gesmundo I, Gallo D, Favaro E, Ghigo E, GranataR. Obestatin: a new metabolic player in the pancreas and white adipose tissue. UBMB Life 2013;65:976–82
Zamrazilova H, Hainer V, Sedlackova D, Papezova H, Kunesova M, Bellisle F, et al. Plasma obestatin levels in normal weight, obese and anorectic women. Physiol Res 2008;57:49–55
Fasshauer M, Blüher M. Adipokines in health and disease. Trends Pharmacol Sci 2015;36:461–70
Seshadri P, Samaha FF, Stern L, Ahima RS, Daily D, Iqbal N. Adipoc ytokine changes caused by low-carbohydrate compared to conve ntional diets in obesity. Metab Syndr